Your Data & You: Who Works for Whom?
Almost every life science company today could likely “check the box” when it comes to having some sort of data analytics aspect of their compliance monitoring program.
The question regulators will start asking companies, however, is no longer “if” a company has adopted data analyses in support of their programs, but rather, “how and to what extent?”
To best safeguard the interests of their organizations, Compliance leaders should be prepared to demonstrate the ways in which their organizations are maximizing the utility of their various data sources to better prevent and deter inappropriate conduct.
"You can corrupt a patient, too." - Assistant U.S. Attorney, Chief of Affirmative Civil Enforcement Unit - U.S. Attorney's Office, District of MassachusettsSynopsis On September 21st - 24th, 2020, Informa Connect-CBI hosted its 6th Annual Compliance Congress for...
"Allowing our customers to be self-sufficient in their compliance auditing is essential to improve efficiency and reduce internal expenses." - John Poulin, Partner and CTO, Helio ArgosSynopsis When Helio Health Group conducted an industry survey, responses indicated...